BCL6 and lymphoma: BCL6-high expressing cells SUDHL5 and K422 displayed more pronounced c-MYC repression following a 1 nM TCIP3 treatment than BCL6-low lymphoma cells OCILY19 and TOLEDO, or the leukemia line K562 (Fig. 5G).